FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 39 filers reported holding FATE THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,534,000 | -58.9% | 387,294 | -66.3% | 0.10% | -60.8% |
| Q2 2017 | $3,729,000 | -52.1% | 1,150,947 | -32.8% | 0.26% | -40.4% |
| Q1 2017 | $7,789,000 | +18.6% | 1,711,958 | -34.6% | 0.43% | +35.0% |
| Q4 2016 | $6,566,000 | -25.6% | 2,615,847 | -7.5% | 0.32% | -21.7% |
| Q3 2016 | $8,823,000 | +129.9% | 2,827,889 | +25.2% | 0.40% | +91.9% |
| Q2 2016 | $3,838,000 | -5.6% | 2,257,920 | 0.0% | 0.21% | -5.4% |
| Q1 2016 | $4,064,000 | -53.6% | 2,257,920 | -13.0% | 0.22% | -47.5% |
| Q4 2015 | $8,750,000 | -31.7% | 2,596,489 | +8.1% | 0.42% | -31.1% |
| Q3 2015 | $12,804,000 | -17.8% | 2,402,224 | -0.2% | 0.62% | +1.3% |
| Q2 2015 | $15,576,000 | +109.1% | 2,407,412 | +58.0% | 0.61% | +92.7% |
| Q1 2015 | $7,449,000 | -4.7% | 1,523,275 | -2.0% | 0.32% | -7.1% |
| Q4 2014 | $7,818,000 | +7.4% | 1,554,175 | +8.9% | 0.34% | +4.0% |
| Q3 2014 | $7,281,000 | -6.6% | 1,427,675 | +19.2% | 0.33% | +9.4% |
| Q2 2014 | $7,797,000 | -26.0% | 1,197,675 | +7.6% | 0.30% | -44.4% |
| Q1 2014 | $10,533,000 | +94.6% | 1,113,475 | +29.2% | 0.54% | +116.9% |
| Q4 2013 | $5,412,000 | – | 861,802 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 716,392 | $11,126,000 | 12.18% |
| Polaris Venture Management Co. V, L.L.C. | 1,139,783 | $17,701,000 | 10.06% |
| Grosvenor Holdings, L.L.C. | 2,285,714 | $35,497,000 | 6.41% |
| Redmile Group, LLC | 11,216,809 | $174,197,000 | 5.83% |
| Casdin Capital, LLC | 2,550,000 | $39,601,500,000 | 4.10% |
| DAFNA Capital Management LLC | 470,000 | $7,299,000 | 2.74% |
| Ghost Tree Capital, LLC | 350,000 | $5,436,000 | 1.38% |
| Artal Group S.A. | 2,000,000 | $31,060,000 | 1.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,952,897 | $30,328,000 | 1.24% |
| Copernicus Capital Management, LLC | 75,000 | $1,165,000 | 1.08% |